At Envision Pharma Group, we believe the future of healthcare lies in the fusion of expert human insight and advanced artificial intelligence. This is what we call combined intelligence, enabling us to accelerate and elevate decision-making, scientific strategy, and communication.
This delivers smarter solutions for patients, healthcare professionals, regulators, and the wider scientific community.
In 2023, we expanded our AI leadership with the acquisition of OKRA.ai – an award‑winning technology company specializing in advanced AI solutions for commercialization, real‑world evidence, data analytics, medical affairs, and pricing across the life sciences sector. Today, this deep AI expertise is seamlessly embedded throughout Envision, powering transformation across three core dimensions:
AI‑enabled teams: Augmenting human expertise with intelligent systems that elevate strategy, creativity, and execution.
AI‑accelerated delivery: Smarter, faster, and more predictive solution delivery powered by advanced analytics and automation.
AI‑infused platforms: Next‑generation platforms built with machine learning at the core to provide real‑time insights and future‑ready capabilities.
Mary Winkles
Head of Global
Medical Training,
Vertex Pharmaceuticals
John McKenna
Global Head of Field-Based
Medical Excellence,
Sanofi
Join Mary Winkles, Head of Global Medical Training at Vertex Pharmaceuticals, and John McKenna, Global Head of Field-Based Medical Excellence at Sanofi, as they explore the future of medical affairs in a technology-driven world.
Discover how the intersection of human expertise and cutting-edge technology is reshaping the field. Gain insights into the strategic role of AI within medical affairs and learn why understanding and interpreting your data is critical for success.
Across Envision, AI is embedded into the way our teams think, collaborate, and deliver. By access to deep life‑sciences expertise we can empower our people with relevant, state‑of‑the‑art AI, to work more efficiently, uncover insights faster, and produce higher‑quality outputs, without ever compromising accuracy, compliance, or trust.
Our experts work hand‑in‑hand with AI engineers to ensure that AI augments, rather than replaces, human judgment. We understand the scientific, regulatory, and operational nuances that matter in medical affairs, and we apply this knowledge to guide safe, responsible, and impactful AI use.
This human‑in‑the‑loop approach enables our teams to stay focused on strategy, insight, and scientific quality while AI accelerates execution. This is how AI becomes part of how we work – not as automation, but as combined intelligence that elevates every stage of delivery.
AI is accelerating how insights are generated, decisions are made, and engagement happens across medical affairs, and Envision is building the future of this transformation responsibly. We apply AI to enhance how knowledge is created, analyzed, and applied – always guided by expert oversight to ensure accuracy, compliance, and trust.
Our human‑in‑the‑loop approach supports everything from scientific content development and literature analysis to real‑time insight generation from advisory boards, MSL interactions, and real‑world data. With a scalable and secure AI infrastructure at our core, we connect content with evidence and evidence with strategy, delivering greater speed, quality, and impact across medical communications today, while future‑proofing for tomorrow.
Evidence: AI-powered literature analysis to sharpen narrative differentiation and strengthen evidence generation.
Expression: Narrative-first scientific communication planning enriched with therapy-area insight and pre-validation through synthetic HCPs.
Engagement: Smart, modular content and AI-driven insight from HCP, MSL, and patient data to continuously refine strategy.
Content creation: AI is redefining how scientific content is developed at scale.
Working alongside our experts, AI accelerates the creation of first‑draft manuscripts, generates clear and accessible summaries for patients, and automates literature reviews to support evidence‑based decision‑making – all while upholding the highest standards of scientific quality, accuracy, and compliance.
Insight generation: AI enables us to surface deeper, more actionable insights by analyzing diverse sources of scientific and stakeholder input.
From distilling themes from HCP and patient advisory boards, to extracting insights from MSL interactions, to powering real‑time knowledge retrieval through medical brain and enhancing medical information responses with contextual intelligence, AI helps teams understand what matters most and make better, faster decisions.
Partnerships and open ecosystem: We are building an open AI ecosystem that integrates leading technologies directly into medical communications workflows.
Through strategic partnerships, we deliver advanced capabilities such as automated scientific communication plans, synthetic KOLs for scenario planning, and AI‑driven semantic search for rapid evidence generation – creating connected, efficient, and insight‑rich processes, all grounded in expert human oversight for quality and compliance.
Having a dedicated AI team that has developed medical algorithms over the past decade, our focus is on transparent AI where every integration operates under rigorous standards for validation and expert oversight, ensuring AI is applied responsibly, ethically, and in full alignment with the needs of medical affairs.
In addition, we enhance our proprietary capabilities through a carefully curated ecosystem of partners, integrating best‑in‑class innovations – from semantic search and synthetic KOLs to automated scientific communication planning. These technologies strengthen how evidence is generated, insights are surfaced, and strategies are validated.
In life sciences, getting it right matters. That’s why our AI roadmap is built on intentional innovation – scalable, secure, and transparent infrastructure guided by expert oversight, designed to future-proof our clients’ organizations while delivering measurable impact for patients.
Explore our latest thinking and how we partner with clients to tackle complex challenges and advance the future of healthcare.
